Medesis Pharma (France) Price on December 19, 2023

ALMDP Stock  EUR 0.35  0.01  2.94%   
If you're considering investing in Medesis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Medesis Pharma stands at 0.35, as last reported on the 14th of December 2024, with the highest price reaching 0.35 and the lowest price hitting 0.33 during the day. Medesis Pharma SA has Sharpe Ratio of -0.0799, which conveys that the firm had a -0.0799% return per unit of risk over the last 3 months. Medesis Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medesis Pharma's Standard Deviation of 6.05, risk adjusted performance of (0.04), and Mean Deviation of 4.21 to check out the risk estimate we provide.
  
Medesis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0799

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsALMDP

Estimated Market Risk

 6.08
  actual daily
54
54% of assets are less volatile

Expected Return

 -0.49
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Medesis Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medesis Pharma by adding Medesis Pharma to a well-diversified portfolio.

Medesis Pharma Valuation on December 19, 2023

It is possible to determine the worth of Medesis Pharma on a given historical date. On December 19, 2023 Medesis was worth 0.9 at the beginning of the trading date compared to the closed value of 0.89. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Medesis Pharma stock. Still, in general, we apply an absolute valuation method to find Medesis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medesis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Medesis Pharma's related companies.
 Open High Low Close Volume
  0.87    0.90    0.87    0.90    3,322  
12/19/2023
  0.90    0.90    0.89    0.89    1,194  
  0.89    0.90    0.87    0.87    2,143  
Backtest Medesis Pharma  |  Medesis Pharma History  |  Medesis Pharma Valuation   PreviousNext  
Open Value
0.9
0.89
Closing Value
19.13
Upside

Medesis Pharma Trading Date Momentum on December 19, 2023

On December 20 2023 Medesis Pharma SA was traded for  0.87  at the closing time. The highest price during the trading period was 0.90  and the lowest recorded bid was listed for  0.87 . The volume for the day was 2.1 K. This history from December 20, 2023 contributed to the next trading day price decline. The overall trading delta to the next closing price was 2.25% . The trading delta at closing time to the current price is 0.00% .

Medesis Pharma SA Fundamentals Correlations and Trends

By evaluating Medesis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Medesis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Medesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Medesis Pharma Stock history

Medesis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medesis Pharma SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medesis Pharma stock prices may prove useful in developing a viable investing in Medesis Pharma
Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France.

Medesis Pharma Stock Technical Analysis

Medesis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Medesis Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Medesis Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Medesis Pharma Period Price Range

Low
December 14, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Medesis Pharma SA cannot be verified against its exchange. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Medesis Pharma December 14, 2024 Market Strength

Market strength indicators help investors to evaluate how Medesis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medesis Pharma shares will generate the highest return on investment. By undertsting and applying Medesis Pharma stock market strength indicators, traders can identify Medesis Pharma SA entry and exit signals to maximize returns

Medesis Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Medesis Pharma's price direction in advance. Along with the technical and fundamental analysis of Medesis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Medesis Stock Analysis

When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.